Evolent Health, Inc. reported a net loss of $429.13 million in Q4, a significant increase from the loss of $30.62 million in the same period last year. The company’s EPS also dropped to -$3.84 from -$0.27. However, after excluding items, Evolent Health reported adjusted earnings of $8.38 million or $0.08 per share. Revenue for the quarter was $468.72 million, down from $646.54 million in the same period last year. This marks a decrease in both earnings and revenue for Evolent Health, Inc. in Q4.

Read more at Nasdaq: Evolent Health, Inc. Q4 Earnings Summary